Beacon Biosignals Integrates CleveMed, SleepView Under Unified Brand
The consolidation brings together CleveMed’s home sleep testing infrastructure and Beacon’s AI-driven brain monitoring technology to advance at-home sleep diagnostics.
The consolidation brings together CleveMed’s home sleep testing infrastructure and Beacon’s AI-driven brain monitoring technology to advance at-home sleep diagnostics.
Age-related differences may be due to a decline in adenosine receptors.
The web-based tool allows clinicians to incorporate the Odds Ratio Product into EEG-based sleep studies, aimed at improving sleep assessment and treatment planning.
The FDA authorizes Beacon Biosignals’ Predetermined Change Control Plan for the Dreem 3S EEG headband, enabling continuous algorithm updates to advance sleep monitoring and clinical-grade EEG analytics.
Read MoreResearchers say the brain-based test could predict whether someone is safe enough to drive or has the mental capacity to sit for an exam.
Read MoreThe study will evaluate the Dreem headband’s ability to monitor sleep and brain activity in...
Read MoreWith 16 independent signal outputs, the stand-alone simulator helps healthcare professionals confirm the precision of various EEG monitoring devices, including sleep study monitors.
Read MoreA survey gathered expert opinions on the future of EEG technology, including the potential for dream analysis and other advancements, assessing their likelihood and timelines.
Read MoreNeurotechnology wearables are creating a “data gold rush” as they collect neural and cognitive data from users, raising privacy concerns and prompting calls for stricter data protection laws in Australia.
Read MoreEEG, celebrating its 100th anniversary, has advanced brain research and treatment, providing insights into sleep medicine and cognitive health.
Read MoreThe research will investigate an approach to identify brain activity associated with dementia during sleep.
Read MoreThe headset is cleared for electroencephalography brain monitoring across hospital, home, ambulance, and air transport environments.
Read MoreResearchers will present studies at SLEEP 2024, covering topics including CPAP withdrawal effects, hypoxic burden in OSA treatment, and new diagnostic tools.
Read MoreLeveraging EEG sensors and generative audio, these earbuds aim to enhance sleep quality through personalized neuro-adaptive stimulation.
Read MoreA study using overnight polysomnography in long-term acute care hospitals links specific sleep EEG findings to failed ventilator weaning.
Read MoreThe collaboration will initially focus on the role of sleep endpoints in clinical trials relating to rare epilepsy syndromes.
Read MoreThe collaboration aims to support the development of novel sleep disorder therapies and improve the diagnostic process for patients.
Read MoreThe newly appointed CEO succeeds co-founder Shawn Regan, who steps into the chairman role.
Read More